Results for tag: "Razadyne"

Razadyne (formerly known as Reminyl) is a drug used to treat mild to moderate Alzheimer's Disease. It is a cholinesterase inhibitor, meaning it works by increasing the amount of a chemical messenger in the brain that is important for memory and thinking. Razadyne is taken orally, usually once or twice a day. It is available in both immediate-release and extended-release forms. Common side effects include nausea, vomiting, diarrhea, and loss of appetite. The Razadyne market is a subset of the larger Alzheimer's Disease drug market. It is a competitive market, with several companies offering similar products. Companies in the Razadyne market include Janssen Pharmaceuticals, Eisai Co., Ltd., and Shire Pharmaceuticals. Show Less Read more